These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8430056)

  • 41. CGRP mediate the isosorbide-5-mononitrate cardiovascular response in healthy Chinese male volunteers through a XOR-independent pathway.
    Liu Z; Zhang B; Guo X; Chen L; Yi D; Cong J; Guo R
    Int J Clin Pharmacol Ther; 2015 Apr; 53(4):325-34. PubMed ID: 25740261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of intravenous and oral isosorbide - 5 - mononitrate.
    Abshagen U; Betzien G; Endele R; Kaufmann B
    Eur J Clin Pharmacol; 1981; 20(4):269-75. PubMed ID: 7308280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of isosorbide-5-mononitrate in human plasma by high-resolution gas chromatography.
    Pastera J; Vyslouzil L; Kvetina J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Feb; 800(1-2):271-4. PubMed ID: 14698265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enantioselective inhibition of the biotransformation and pharmacological actions of isoidide dinitrate by diphenyleneiodonium sulphate.
    Ratz JD; McGuire JJ; Bennett BM
    Br J Pharmacol; 1999 Jan; 126(1):61-8. PubMed ID: 10051121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
    Geigenberger A; Degen J; Maier-Lenz H
    Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.
    Thadani U; Whitsett T
    Clin Pharmacokinet; 1988 Jul; 15(1):32-43. PubMed ID: 3135973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gas chromatographic-mass spectrometric determination of isosorbide 5-mononitrate in human plasma.
    Lauro-Marty C; Lartigue-Mattei C; Chabard JL; Beyssac E; Aiache JM; Madesclaire M
    J Chromatogr B Biomed Appl; 1995 Jan; 663(1):153-9. PubMed ID: 7704204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The plasma concentrations of isosorbide 5-mononitrate (5-ISMN) administered in an extended-release form to patients with acute myocardial infarction.
    McClennen W; Hornestam B; Jonsson UE; Held P
    Br J Clin Pharmacol; 1995 Jun; 39(6):704-8. PubMed ID: 7654494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of organic nitrates in man: an overview.
    Bogaert MG
    Eur Heart J; 1988 Jan; 9 Suppl A():33-7. PubMed ID: 3137070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved extraction procedure for the assay of isosorbide-5-mononitrate in serum.
    Pennings JM; de Haas JM
    J Chromatogr B Biomed Appl; 1996 Jan; 675(2):332-5. PubMed ID: 8852723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.
    Strein K; Sponer G; Bartsch W; Müller-Beckmann B; Dietmann K
    J Pharmacol Exp Ther; 1984 Jun; 229(3):787-92. PubMed ID: 6726657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of emotional stress on pharmacokinetics of isosorbide dinitrate intraperitoneally administered to rats.
    Gomita Y; Furuno K; Araki Y
    Acta Med Okayama; 1990 Feb; 44(1):51-3. PubMed ID: 2330846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolism of isosorbide dinitrate in the isolated perfused rabbit lung.
    Mayer PR; Lubawy WC; McNamara PJ; Kostenbauder HB
    J Pharm Sci; 1983 Jul; 72(7):785-9. PubMed ID: 6886987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mononitrates: defining the ideal long-acting nitrate.
    Frishman WH; Amsterdam E; Glasser SP; Thadani U
    Clin Ther; 1994; 16(2):130-9; discussion 129. PubMed ID: 7914830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical chronopharmacology of oral nitrates.
    Lemmer B; Scheidel B; Stenzhorn G; Blume H; Lenhard G; Grether D; Renczes J; Becker HJ
    Z Kardiol; 1989; 78 Suppl 2():61-3; discussion 64-7. PubMed ID: 2588762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
    Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
    Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of electric foot shock on pharmacokinetics of isosorbide dinitrate orally administered to rats.
    Gomita Y; Furuno K; Araki Y
    Jpn J Pharmacol; 1989 Feb; 49(2):297-9. PubMed ID: 2733266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioavailability and pharmacokinetics of a new isosorbide dinitrate spray preparation in healthy volunteers.
    Hutt V; Theodor R; Pabst G; Lutz D; Bonn R; Fritschi E
    Arzneimittelforschung; 1993 Aug; 43(8):842-6. PubMed ID: 8216439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the time to onset of action on myocardial ischaemia following intravenous administration of isosorbide dinitrate and 5-isosorbide mononitrate in Chinese patients.
    Wu ZG; Li JN; Fan M; Shang YK; Zhang YW; Bai J; Ding R; Cheng JM; Liang C
    Arzneimittelforschung; 2004; 54(5):275-9. PubMed ID: 15212189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man.
    Abshagen U; Spörl-Radun S
    Eur J Clin Pharmacol; 1981; 19(6):423-9. PubMed ID: 7250175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.